D
PharmaCorp Rx Inc. PCRX.V
TSX
Recommendation
Sell
Prev Close
$0.48
Volume
--
Avg Vol (90D)
29,937
Market Cap
$39.54M
Dividend & Yield
--
52-Week Range
$0.43 - $0.875
P/E (TTM)
--
EPS (TTM)
-$0.0293
My Lists My Alerts
Weiss Ratings PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -0.66
Price History PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return -4.00%
30-Day Total Return -14.29%
60-Day Total Return -5.88%
90-Day Total Return -18.64%
Year to Date Total Return 9.09%
1-Year Total Return 128.57%
2-Year Total Return 140.00%
3-Year Total Return --
5-Year Total Return --
52-Week High % Change -45.14%
52-Week Low % Change 11.63%
Price PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $0.88
52-Week Low Price $0.43
52-Week Low Price (Date) Aug 06, 2024
52-Week High Price (Date) Aug 28, 2024
Valuation PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 39.54M
Enterprise Value 21.67M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.03
Earnings Per Share Growth 211.70%
Price/Earnings To Growth --
Price/Sales (TTM) 53.33
Price/Book (Q) 2.54
Enterprise Value/Revenue (TTM) 21.19
Price $0.48
Enterprise Value/EBITDA (TTM) -17.84
Enterprise Value/EBIT -13.50
Market Cap Category Nano Cap
Dividends and Shares PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 113.16M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number --
Address 303 Wellman Lane Saskatoon, SK S7T 0J1
Website www.pharmacorprx.ca
Country Canada
Year Founded 2021
Profitability PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -157.00%
Profit Margin -142.75%
Management Effectiveness PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -7.84%
Return on Equity --
Income Statement PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 1.02M
Total Revenue (TTM) 1.02M
Revenue Per Share $0.01
Gross Profit (TTM) 376.70K
EBITDA (TTM) -1.21M
EBIT (TTM) -1.61M
Net Income (TTM) -1.46M
Net Income Avl. to Common (TTM) -1.46M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -853.19%
EPS Diluted (TTM) -0.03
EPS Diluted Growth (Q YOY) -70.27%
Balance Sheet PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 19.75M
Cash Per Share (Q) $0.17
Total Current Assets (Q) 20.20M
Total Preferred Equity (Q) --
Total Equity (Q) 22.26M
Current Ratio (Q) 42.613
Book Value Per Share (Q) $0.19
Total Assets (Q) 23.75M
Total Current Liabilities (Q) 474.10K
Total Debt (Q) 732.60K
Total Liabilities (Q) 1.49M
Total Common Equity (Q) 22.07M
Cash Flow PCRX.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -1.47M
Cash from Financing (TTM) 20.07M
Net Change in Cash (TTM) 17.65M
Levered Free Cash Flow (TTM) -530.80K
Cash from Operations (TTM) -939.90K
Weiss Ratings